TRIO Pharmaceuticals

Website
Current Valuation
$17.0M
As of November 7, 2024
Total Funding Raised
$8.5M
Last Round
Later Stage VC

$6.0M

Last Funding
Nov 2024

Funding date

Capital Efficiency
2.00x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

TRIO Pharmaceuticals is currently valued at $17.0M as of November 7, 2024. The company has raised a total of $8.5M in funding.

Capital Efficiency

With a capital efficiency ratio of 2.00x, TRIO Pharmaceuticals has achieved a valuation that is 2.00 times the total capital raised.

Track TRIO Pharmaceuticals Valuation Updates

Get notified when TRIO Pharmaceuticals raises new funding or valuation changes

Explore More Data
Detailed analysis for TRIO Pharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock TRIO Pharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is TRIO Pharmaceuticals Worth in 2026?

TRIO Pharmaceuticals is a leading private company in the technology sector. Track TRIO Pharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How TRIO Pharmaceuticals Valuation is Determined

Private company valuations like TRIO Pharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.